chevron_left Categories

Other related webinars

New FDA requirements: Recent changes to FDA requ...

Friday, 10th February, 2012
Time : 02:00 PM EST | 11:00 AM PST

Assessing off-label drug use after approval : re...

Friday, 9th March, 2012
Time : 02:00 PM EST | 11:00 AM PST

Reducing risk of international drug development ...

Wednesday, 11th April, 2012
Time : 02:00 PM EST | 11:00 AM PST

Use of risk management plans for integrated bene...

Thursday, 14th June, 2012
Time : 02:00 PM EST | 11:00 AM PST

FDA requirements for Risk Evaluation and Managem...

Friday, 29th June, 2012
Time : 02:00 PM EST | 11:00 AM PST

Enterprise Project Portfolio Management - Moving...

Friday, 12th October, 2012
Time : 02:00 PM EST | 11:00 AM PST

The new concept of Effective Risk Management : A...

Friday, 26th October, 2012
Time : 02:00 PM IST | 09:30 AM CET

Managerial Decision-Making Under Risk and Uncert...

Wednesday, 21st November, 2012
Time : 02:00 PM EST | 11:00 AM PST

Crossing the chasm from Traditional Project Man...

Friday, 7th December, 2012
Time : 02:00 PM EST | 11:00 AM PST

Risk assessment: approaches to avoid medication ...

Monday, 24th December, 2012
Time : 02:00 PM EST | 11:00 AM PST

Risks of not achieving comparability of biologic...

Friday, 18th January, 2013
Time : 02:00 PM EST | 11:00 AM PST

Risk Analysis & Risk Assessment in Drug Discover...

Monday, 4th February, 2013
Time : 02:00 PM EST | 11:00 AM PST

Building A Successful and Sustainable PMO

Friday, 8th February, 2013
Time : 02:00 PM EST | 11:00 AM PST

Achieving the lifecycle approach to process vali...

Wednesday, 20th March, 2013
Time : 02:00 PM EST | 11:00 AM PST

Risk Based Approach to the Management and Monito...

Friday, 3rd May, 2013
Time : 02:00 PM EST | 11:00 AM PST

How to Write a Scientific Article

Friday, 5th June, 2015
Time : 11:00 AM EST | 05:00 PM CET

The New Pipeline Physics Model : Manage pipeline...

Friday, 23rd October, 2015
Time : 01:00 PM EDT | 10:00 AM PDT

EMA & US FDA view of regulatory aspects of pha...

Friday, 19th February, 2016
Time : 01:00 PM EDT | 10:00 AM PDT

FDA and Safety Monitoring

Friday, 15th July, 2016
Time : 01:00 PM EDT | 10:00 AM PDT

Panel Discussion on Quality Management Principle...

Monday, 20th February, 2017
Time : 04:00 PM IST | 11:30 AM BST

Back to the basics: Refresh your epidemiology kn...

Friday, 17th July, 2020
Time : 121:00 PM EST | 10:00 AM PST

2021 Guidelines for Office and Outpatient Visits...

Friday, 8th January, 2021
Time : 01:00 PM EDT | 10:00 AM PDT

Latest News

Monday, 12th April, 2021
Time : |

Recorded Webinar

FDA and Safety Monitoring

timelapse 60 mins with 10-15 mins of Q and A

Note:

This webinar occured in the past
Along with recorded webinar, copy of presentation slides will be shared
Recorded Webinar can be played unlimited times

Speaker/Presenter

Short Abstract

Safety Monitoring: My team was one of the first to pioneer pharmacovigilance and safety monitoring best practices under the Risk Management domain; which have being widely adopted across the industry. By now the FDA has embraced Safety Monitoring by setting out guidance for greater real time reporting and engaging patients directly into reporting Adverse Events (AEs). Will discuss the process, technology and training required to meet Safety Monitoring standards. The increasing FDA interest in Social Media self reporting through tweeter vs. reporting through traditional channels. Lessons from the intelligence community applied to the pharma and medical device surveillance program. Finally the steps for setting up a comprehensive Key Risk Indicator tracking system that streams data from multiple safety monitoring systems. Ultimately having a unified regulatory strategy in where Safety Monitoring is the tip of the spear continuously increasing safety and efficacy.
The presentation will cover the following areas

  • Guidance for Clinical Investigations using a Risk –Based Approach to Monitoring
  • Increased requirements or cardiac and respiratory safety across all therapeutic application drugs
  • Process and technologies geometrically expanding FDA expectations for early signal detections
  • Incorporating Safety Monitoring in your operations
  • Consistently improving your results and targeted outcomes


Apply for this webinar

Content Disclaimer

Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility for the content of such links and websites.

//